ApprovalTrail

Approval · Notice of Compliance 489 · 2002

SUSTIVA: Notice of Compliance 489

Issued July 4, 2002

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
489
Date
July 4, 2002
Product type
Prescription Pharmaceutical
Submission
Supplement to a New Drug Submission (SNDS), supplement
Submission class
Other
Reason
New strengths; product monograph update: revised dosing of the capsules and tablets to recommend taking on an empty stomach
Therapeutic class
Antiretroviral agent

Products in this notice

BrandDINStatus today
SUSTIVA02246044—
SUSTIVA02246045Cancelled Post Market

Medicinal ingredients